{
    "project_id": "171638",
    "broad_study_type": "observational",
    "narrow_study_type": "cohort_study",
    "trial_phase": "N/A",
    "observational_timeframe": "longitudinal",
    "justification": "In the summer of 2004 and following the award of a CIHR operating grant we initiated a large longitudinal study on neurocognitive and neuroimaging markers of clinical outcome following a first episode of psychosis...we propose to pursue this unique longitudinal study involving an already well characterized large FEP patient cohort for understanding predictors of variations in remission and functional recovery.",
    "data_type": "canadian",
    "ipd_used": "individual",
    "novelty_statement": "Identifying the early neurocognitive and neuroimaging markers of full remission on the one hand and the progressive changes that may occur over time in non-remitted patients following a first episode of psychosis may facilitate early identification of patients with poor prognosis and provide data for future development of different biological and psychosocial treatment approaches in the early course of the illness.",
    "replication_study": "yes",
    "target_population_size": "N/A",
    "age_range": "adults",
    "gender_focus": "mixed",
    "vulnerable_populations": "yes",
    "rare_disease": "no",
    "population_description": "patients with a first episode of psychosis",
    "intervention_category": "N/A",
    "intervention_name": "N/A",
    "control_type": "no_control",
    "dose_response": "no",
    "combination_therapy": "no",
    "personalized_medicine": "no",
    "primary_outcome": "remission and functional recovery",
    "primary_outcome_type": "functional",
    "safety_focus": "no",
    "quality_of_life": "yes",
    "biomarker_endpoints": "yes",
    "time_to_event": "no",
    "composite_endpoint": "yes",
    "ai_machine_learning": "no",
    "digital_health": "no",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "no",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "no",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "no",
    "policy_evaluation": "no",
    "health_system_integration": "no",
    "scalability_assessment": "no",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "yes",
    "novel_biostatistics": "no",
    "patient_reported_outcomes": "yes",
    "real_world_evidence": "no",
    "industry_partnership": "no",
    "patient_engagement": "yes",
    "community_based": "no",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "no",
    "ethics_focus": "yes",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "mental_health",
    "disease_stage": "early",
    "comorbidity_focus": "no",
    "pandemic_related": "no",
    "environmental_health": "no",
    "social_determinants": "no",
    "health_equity": "no",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "no",
    "registry_linkage": "no",
    "cohort_establishment": "yes",
    "platform_trial": "no",
    "study_duration": "long_term",
    "multicenter": "yes",
    "healthcare_setting": "hospital",
    "disease_area": "schizophrenia",
    "methodology_innovation": "longitudinal study of neurocognitive and neuroimaging markers of remission in first episode psychosis",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "no"
} 